Related Experiment Video
Updated: Apr 7, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Neonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and Treatment
Thomas Götze1, Holger Blessing1, Christian Grillhösl1
1Department for Pediatric and Adolescent Medicine, Friedrich-Alexander University of Erlangen-Nuremberg , Erlangen , Germany.
Insights
Prolonged neonatal jaundice requires prompt investigation to differentiate benign cases from serious conditions like neonatal cholestasis (NC). Early diagnosis and treatment, especially for biliary atresia, are crucial for infant health.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Hepatology
Background:
- Cholestatic jaundice in infants is difficult to diagnose, often confused with physiologic jaundice.
- Delayed diagnosis of neonatal cholestasis (NC) can lead to severe liver disease.
- Prolonged jaundice beyond two weeks necessitates investigation.
Purpose of the Study:
- To provide a systematic approach for diagnosing neonatal cholestasis.
- To facilitate early recognition and timely management of cholestatic jaundice.
- To review diagnostic procedures and differential diagnoses for neonatal cholestasis.
Main Methods:
- Investigate infants with prolonged jaundice (over 14 days) for cholestasis.
- Measure conjugated bilirubin levels in jaundiced infants.
- Employ a systematic work-up including new diagnostic methods.
Main Results:
- Early identification of neonatal cholestasis is essential for prompt, life-saving therapy.
- Timely diagnosis of biliary atresia, a common cause of NC, is critical for surgical intervention.
- A structured diagnostic strategy improves the recognition of cholestasis.
Conclusions:
- All infants with prolonged jaundice require evaluation for neonatal cholestasis.
- Prompt diagnosis and management of NC, particularly biliary atresia, improve outcomes.
- This review offers a clinical overview to guide the diagnosis of cholestasis in neonates.
Abstract:
Cholestatic jaundice in early infancy is a complex diagnostic problem. Misdiagnosis of cholestasis as physiologic jaundice delays the identification of severe liver diseases. In the majority of infants, prolonged physiologic jaundice represent benign cases of breast milk jaundice, but few among them are masked and caused by neonatal cholestasis (NC) that requires a prompt diagnosis and treatment. Therefore, a prolonged neonatal jaundice, longer than 2 weeks after birth, must always be investigated because an early diagnosis is essential for appropriate management. To rapidly identify the cases with cholestatic jaundice, the conjugated bilirubin needs to be determined in any infant presenting with prolonged jaundice at 14 days of age with or without depigmented stool. Once NC is confirmed, a systematic approach is the key to reliably achieve the diagnosis in order to promptly initiate the specific, and in many cases, life-saving therapy. This strategy is most important to promptly identify and treat infants with biliary atresia, the most common cause of NC, as this requires a hepatoportoenterostomy as soon as possible. Here, we provide a detailed work-up approach including initial treatment recommendations and a clinically oriented overview of possible differential diagnoses in order to facilitate the early recognition and a timely diagnosis of cholestasis. This approach warrants a broad spectrum of diagnostic procedures and investigations including new methods that are described in this review.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Endoscopic Procedures V: ERCP
Patient...
